{"pmid":32473912,"title":"Transcatheter mitral valve repair with MitraClip for severe mitral regurgitation and cardiogenic shock during the COVID-19 pandemic.","text":["Transcatheter mitral valve repair with MitraClip for severe mitral regurgitation and cardiogenic shock during the COVID-19 pandemic.","Transcatheter mitral valve repair with MitraClip (Abbott) is largely an elective procedure. The ongoing coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care systems; in many cases elective interventions have been curtailed. Patients with severe mitral regurgitation (MR) and cardiogenic shock are high-risk surgical candidates and at risk of a poor outcome without intervention. The American College of Cardiology (ACC) and the Society of Coronary Angiography and Interventions (SCAI) recently proposed joint guidance on triage of structural heart disease (SHD) interventions during the COVID-19 pandemic. We present two illustrative cases of severe MR and cardiogenic shock that were successfully treated with MitraClip amidst the COVID-19 pandemic with good outcomes at short term follow-up.","Cardiovasc Revasc Med","Chitturi, Kalyan R","Faza, Nadeen N","Little, Stephen H","Kleiman, Neal S","Reardon, Michael J","Goel, Sachin S","32473912"],"abstract":["Transcatheter mitral valve repair with MitraClip (Abbott) is largely an elective procedure. The ongoing coronavirus disease 2019 (COVID-19) pandemic has posed challenges to health care systems; in many cases elective interventions have been curtailed. Patients with severe mitral regurgitation (MR) and cardiogenic shock are high-risk surgical candidates and at risk of a poor outcome without intervention. The American College of Cardiology (ACC) and the Society of Coronary Angiography and Interventions (SCAI) recently proposed joint guidance on triage of structural heart disease (SHD) interventions during the COVID-19 pandemic. We present two illustrative cases of severe MR and cardiogenic shock that were successfully treated with MitraClip amidst the COVID-19 pandemic with good outcomes at short term follow-up."],"journal":"Cardiovasc Revasc Med","authors":["Chitturi, Kalyan R","Faza, Nadeen N","Little, Stephen H","Kleiman, Neal S","Reardon, Michael J","Goel, Sachin S"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32473912","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.carrev.2020.05.030","keywords":["covid-19","cardiogenic shock","mitraclip","mitral regurgitation"],"topics":["Prevention"],"weight":1,"_version_":1668341932724584448,"score":9.490897,"similar":[{"pmid":32250751,"title":"Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement.","text":["Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement.","The COVID-19 pandemic has strained health care resources around the world causing many institutions to curtail or stop elective procedures. This has resulted in the inability to care for patients valvular and structural heart disease (SHD) in a timely fashion potentially placing these patients at increased risk for adverse cardiovascular complications including congestive heart failure and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic versus the risk of delaying a needed procedure. In this document, we suggest guidelines as to how to triage patients in need of SHD interventions and provide a framework of how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, we address the triage of patients in need of trans-catheter aortic valve replacement and percutaneous mitral valve repair. We also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.","JACC Cardiovasc Interv","Shah, Pinak B","Welt, Frederick G P","Mahmud, Ehtisham","Phillips, Alistair","Kleiman, Neal S","Young, Michael N","Sherwood, Matthew","Batchelor, Wayne","Wang, Dee Dee","Davidson, Laura","Wyman, Janet","Kadavath, Sabeeda","Szerlip, Molly","Hermiller, James","Fullerton, David","Anwaruddin, Saif","32250751"],"abstract":["The COVID-19 pandemic has strained health care resources around the world causing many institutions to curtail or stop elective procedures. This has resulted in the inability to care for patients valvular and structural heart disease (SHD) in a timely fashion potentially placing these patients at increased risk for adverse cardiovascular complications including congestive heart failure and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic versus the risk of delaying a needed procedure. In this document, we suggest guidelines as to how to triage patients in need of SHD interventions and provide a framework of how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, we address the triage of patients in need of trans-catheter aortic valve replacement and percutaneous mitral valve repair. We also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic."],"journal":"JACC Cardiovasc Interv","authors":["Shah, Pinak B","Welt, Frederick G P","Mahmud, Ehtisham","Phillips, Alistair","Kleiman, Neal S","Young, Michael N","Sherwood, Matthew","Batchelor, Wayne","Wang, Dee Dee","Davidson, Laura","Wyman, Janet","Kadavath, Sabeeda","Szerlip, Molly","Hermiller, James","Fullerton, David","Anwaruddin, Saif"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32250751","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.jcin.2020.04.001","topics":["Prevention"],"weight":1,"_version_":1666138491016183808,"score":361.34122},{"pmid":32251546,"title":"Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement.","text":["Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the Coronavirus Disease 2019 (COVID-19) Pandemic: An ACC /SCAI Consensus Statement.","The COVID-19 pandemic has strained health care resources around the world causing many institutions to curtail or stop elective procedures. This has resulted in the inability to care for patients valvular and structural heart disease (SHD) in a timely fashion potentially placing these patients at increased risk for adverse cardiovascular complications including congestive heart failure and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic versus the risk of delaying a needed procedure. In this document, we suggest guidelines as to how to triage patients in need of SHD interventions and provide a framework of how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, we address the triage of patients in need of trans-catheter aortic valve replacement and percutaneous mitral valve repair. We also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic. This article is protected by copyright. All rights reserved.","Catheter Cardiovasc Interv","Shah, Pinak B","Welt, Frederick G P","Mahmud, Ehtisham","Phillips, Alistair","Kleiman, Neal S","Young, Michael N","Sherwood, Matthew","Batchelor, Wayne","Wang, Dee Dee","Davidson, Laura","Wyman, Janet","Kadavath, Sabeeda","Szerlip, Molly","Hermiller, James","Fullerton, David","Anwaruddin, Saif","32251546"],"abstract":["The COVID-19 pandemic has strained health care resources around the world causing many institutions to curtail or stop elective procedures. This has resulted in the inability to care for patients valvular and structural heart disease (SHD) in a timely fashion potentially placing these patients at increased risk for adverse cardiovascular complications including congestive heart failure and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic versus the risk of delaying a needed procedure. In this document, we suggest guidelines as to how to triage patients in need of SHD interventions and provide a framework of how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, we address the triage of patients in need of trans-catheter aortic valve replacement and percutaneous mitral valve repair. We also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic. This article is protected by copyright. All rights reserved."],"journal":"Catheter Cardiovasc Interv","authors":["Shah, Pinak B","Welt, Frederick G P","Mahmud, Ehtisham","Phillips, Alistair","Kleiman, Neal S","Young, Michael N","Sherwood, Matthew","Batchelor, Wayne","Wang, Dee Dee","Davidson, Laura","Wyman, Janet","Kadavath, Sabeeda","Szerlip, Molly","Hermiller, James","Fullerton, David","Anwaruddin, Saif"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32251546","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/ccd.28910","topics":["Prevention"],"weight":1,"_version_":1666138491023523840,"score":352.6296},{"pmid":32427416,"title":"COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.","text":["COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.","A patient with coronavirus disease 19 (COVID-19) developed acute myocardial infarction (AMI) complicated by extensive coronary thrombosis and cardiogenic shock. She underwent percutaneous coronary intervention and placement of a mechanical circulatory support device but subsequently died from shock. This report illustrates the challenges in managing patients with COVID-19, AMI, and cardiogenic shock.","Catheter Cardiovasc Interv","Harari, Rafael","Bangalore, Sripal","Chang, Ernest","Shah, Binita","32427416"],"abstract":["A patient with coronavirus disease 19 (COVID-19) developed acute myocardial infarction (AMI) complicated by extensive coronary thrombosis and cardiogenic shock. She underwent percutaneous coronary intervention and placement of a mechanical circulatory support device but subsequently died from shock. This report illustrates the challenges in managing patients with COVID-19, AMI, and cardiogenic shock."],"journal":"Catheter Cardiovasc Interv","authors":["Harari, Rafael","Bangalore, Sripal","Chang, Ernest","Shah, Binita"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32427416","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/ccd.28992","keywords":["covid-19","cardiogenic shock","myocardial infarction"],"topics":["Case Report"],"weight":1,"_version_":1667252837931810817,"score":341.0827},{"pmid":32275347,"title":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock.","text":["Myocardial localization of coronavirus in COVID-19 cardiogenic shock.","We describe the first case of acute cardiac injury directly linked to myocardial localization of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in a 69-year-old patient with flu-like symptoms rapidly degenerating into respiratory distress, hypotension, and cardiogenic shock. The patient was successfully treated with venous-arterial extracorporeal membrane oxygenation (ECMO) and mechanical ventilation. Cardiac function fully recovered in 5 days and ECMO was removed. Endomyocardial biopsy demonstrated low-grade myocardial inflammation and viral particles in the myocardium suggesting either a viraemic phase or, alternatively, infected macrophage migration from the lung.","Eur J Heart Fail","Tavazzi, Guido","Pellegrini, Carlo","Maurelli, Marco","Belliato, Mirko","Sciutti, Fabio","Bottazzi, Andrea","Sepe, Paola Alessandra","Resasco, Tullia","Camporotondo, Rita","Bruno, Raffaele","Baldanti, Fausto","Paolucci, Stefania","Pelenghi, Stefano","Iotti, Giorgio Antonio","Mojoli, Francesco","Arbustini, Eloisa","32275347"],"abstract":["We describe the first case of acute cardiac injury directly linked to myocardial localization of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in a 69-year-old patient with flu-like symptoms rapidly degenerating into respiratory distress, hypotension, and cardiogenic shock. The patient was successfully treated with venous-arterial extracorporeal membrane oxygenation (ECMO) and mechanical ventilation. Cardiac function fully recovered in 5 days and ECMO was removed. Endomyocardial biopsy demonstrated low-grade myocardial inflammation and viral particles in the myocardium suggesting either a viraemic phase or, alternatively, infected macrophage migration from the lung."],"journal":"Eur J Heart Fail","authors":["Tavazzi, Guido","Pellegrini, Carlo","Maurelli, Marco","Belliato, Mirko","Sciutti, Fabio","Bottazzi, Andrea","Sepe, Paola Alessandra","Resasco, Tullia","Camporotondo, Rita","Bruno, Raffaele","Baldanti, Fausto","Paolucci, Stefania","Pelenghi, Stefano","Iotti, Giorgio Antonio","Mojoli, Francesco","Arbustini, Eloisa"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275347","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1002/ejhf.1828","keywords":["cardiac injury","cardiogenic shock","coronavirus","extracorporeal membrane oxygenation","myocardial inflammation","sars-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1666138491725021184,"score":253.75835},{"pmid":32363334,"pmcid":"PMC7194983","title":"Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO).","text":["Cardiovascular Collapse in COVID-19 Infection: The Role of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO).","COVID-19 has been associated with cardiovascular complications including acute cardiac injury, heart failure and cardiogenic shock. The role of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in the event of COVID-19-associated cardiovascular collapse has not yet been established. We reviewed existing literature surrounding the role of VA-ECMO in the treatment of coronavirus-related cardiovascular collapse. COVID-19 is associated with higher incidence of cardiovascular complications compared to previous coronavirus outbreaks (SARS-CoV, MERS-CoV). We found only one case report from China where COVID-19-associated fulminant myocarditis and cardiogenic shock (CS) was successfully rescued using VA-ECMO as a bridge to recovery (BTR). We identified potential clinical scenarios (cardiac injury, myocardial infarction with and without obstructive coronary artery disease, viral myocarditis, and decompensated heart failure) leading to CS and risk factors for poor/uncertain benefit (age, sepsis, mixed/predominantly vasodilatory shock, prothrombotic state and/or coagulopathy, severe acute respiratory distress syndrome, multi-organ failure or high-risk prognostic scores) specific to using VA-ECMO as BTR in COVID-19 infection. Additional considerations and proposed recommendations specific to the COVID-19 pandemic were formulated with guidance from published data and expert consensus. A small subset of patients with cardiovascular complications from COVID-19 infection may progress to refractory CS. Accepting that resource scarcity may be the overwhelming concern for healthcare systems during this pandemic, VA-ECMO can be considered in highly selected cases of refractory CS and echocardiographic evidence of biventricular failure. The decision to initiate this therapy should take into consideration availability of resources, perceived benefit as well as risks of transmitting disease.","CJC Open","Chow, Justin","Alhussaini, Anhar","Calvillo-Arguelles, Oscar","Billia, Filio","Luk, Adriana","32363334"],"abstract":["COVID-19 has been associated with cardiovascular complications including acute cardiac injury, heart failure and cardiogenic shock. The role of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in the event of COVID-19-associated cardiovascular collapse has not yet been established. We reviewed existing literature surrounding the role of VA-ECMO in the treatment of coronavirus-related cardiovascular collapse. COVID-19 is associated with higher incidence of cardiovascular complications compared to previous coronavirus outbreaks (SARS-CoV, MERS-CoV). We found only one case report from China where COVID-19-associated fulminant myocarditis and cardiogenic shock (CS) was successfully rescued using VA-ECMO as a bridge to recovery (BTR). We identified potential clinical scenarios (cardiac injury, myocardial infarction with and without obstructive coronary artery disease, viral myocarditis, and decompensated heart failure) leading to CS and risk factors for poor/uncertain benefit (age, sepsis, mixed/predominantly vasodilatory shock, prothrombotic state and/or coagulopathy, severe acute respiratory distress syndrome, multi-organ failure or high-risk prognostic scores) specific to using VA-ECMO as BTR in COVID-19 infection. Additional considerations and proposed recommendations specific to the COVID-19 pandemic were formulated with guidance from published data and expert consensus. A small subset of patients with cardiovascular complications from COVID-19 infection may progress to refractory CS. Accepting that resource scarcity may be the overwhelming concern for healthcare systems during this pandemic, VA-ECMO can be considered in highly selected cases of refractory CS and echocardiographic evidence of biventricular failure. The decision to initiate this therapy should take into consideration availability of resources, perceived benefit as well as risks of transmitting disease."],"journal":"CJC Open","authors":["Chow, Justin","Alhussaini, Anhar","Calvillo-Arguelles, Oscar","Billia, Filio","Luk, Adriana"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32363334","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.cjco.2020.04.003","keywords":["extracorporeal membrane oxygenation","cardiogenic shock","coronavirus","mechanical circulatory support","myocarditis"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1666138496055640065,"score":234.88255}]}